Cite Filings / STLN / 0001104659-21-128994
Feed Companies Filings Check
Sign in
8-K

Current Report

Starling Oncology, Inc. · Filed 2021-10-22 · Acc 0001104659-21-128994

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , tm2130838d1_8k.htm

Around this filing

  • 2021-11-18 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Other events
  • 2021-10-22 EFFECT Notice of Effectiveness
  • 2021-10-22 425 Prospectus/Communication re Business Combination
  • 2021-10-22 8-K Other events
  • 2021-10-22 424B3 Prospectus
  • 2021-10-21 CORRESP Correspondence Between Filers and SEC Staff
  • 2021-10-12 8-K Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2130838d1_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…